NO20000655L - 8-substituerte-9H-1,3-Dioxolo/4,5- h//2,3/benzodiazepinderivater, som AMPA/KAINAT reseptorinhibitorer - Google Patents
8-substituerte-9H-1,3-Dioxolo/4,5- h//2,3/benzodiazepinderivater, som AMPA/KAINAT reseptorinhibitorerInfo
- Publication number
- NO20000655L NO20000655L NO20000655A NO20000655A NO20000655L NO 20000655 L NO20000655 L NO 20000655L NO 20000655 A NO20000655 A NO 20000655A NO 20000655 A NO20000655 A NO 20000655A NO 20000655 L NO20000655 L NO 20000655L
- Authority
- NO
- Norway
- Prior art keywords
- dioxolo
- substituted
- ampa
- kainat
- receptor inhibitors
- Prior art date
Links
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 title abstract 3
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title 1
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title 1
- 108091006082 receptor inhibitors Proteins 0.000 title 1
- -1 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002860 competitive effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- BMQVDVJKPMGHDO-UHFFFAOYSA-K magnesium;potassium;chloride;sulfate;trihydrate Chemical compound O.O.O.[Mg+2].[Cl-].[K+].[O-]S([O-])(=O)=O BMQVDVJKPMGHDO-UHFFFAOYSA-K 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9701380A HUP9701380A3 (en) | 1997-08-12 | 1997-08-12 | New 8-substituted-9h-1,3-dioxolo-[4,5-h][2,3]-benzodiazepine derivatives, pharmaceutical compositions containing them as active component, and process for producing them |
| HU9701381A HUP9701381A3 (en) | 1997-08-12 | 1997-08-12 | New 7,8-dihydro-8,8-disubstituted-9h-1,3-dioxolo-[4,5-h][2,3]-benzodiazepine derivatives, pharmaceutical compositions containing them as active component, and process for producing them |
| PCT/HU1998/000075 WO1999007707A1 (en) | 1997-08-12 | 1998-08-07 | 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h//2,3/BENZODIAZEPINE DERIVATIVES, AS AMPA/KAINATE RECEPTOR INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000655D0 NO20000655D0 (no) | 2000-02-09 |
| NO20000655L true NO20000655L (no) | 2000-04-10 |
Family
ID=89995497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000655A NO20000655L (no) | 1997-08-12 | 2000-02-09 | 8-substituerte-9H-1,3-Dioxolo/4,5- h//2,3/benzodiazepinderivater, som AMPA/KAINAT reseptorinhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6562810B1 (ru) |
| EP (1) | EP1003749B1 (ru) |
| JP (1) | JP2001512730A (ru) |
| KR (1) | KR20010022862A (ru) |
| CN (1) | CN1109033C (ru) |
| AT (1) | ATE252586T1 (ru) |
| AU (1) | AU735490B2 (ru) |
| BR (1) | BR9812120A (ru) |
| CA (1) | CA2300302A1 (ru) |
| DE (1) | DE69819166T2 (ru) |
| DK (1) | DK1003749T3 (ru) |
| NO (1) | NO20000655L (ru) |
| NZ (1) | NZ503300A (ru) |
| PL (1) | PL338680A1 (ru) |
| RU (1) | RU2208013C2 (ru) |
| SK (1) | SK1772000A3 (ru) |
| UA (1) | UA67749C2 (ru) |
| WO (1) | WO1999007707A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9900354A3 (en) * | 1999-02-15 | 2001-02-28 | Egyt Gyogyszervegyeszeti Gyar | Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation |
| HU227128B1 (en) * | 1999-07-07 | 2010-07-28 | Egyt Gyogyszervegyeszeti Gyar | New 2,3-benzodiazepine derivatives |
| US6858605B2 (en) | 2003-02-04 | 2005-02-22 | Ivax Drug Research Institute, Ltd. | Substituted 2,3-benzodiazepine derivatives |
| CN100558834C (zh) * | 2006-07-21 | 2009-11-11 | 华南理工大学 | 一种环保型干粉涂料及其制备方法 |
| FR2972454B1 (fr) * | 2011-03-08 | 2013-03-01 | Servier Lab | Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| HU230684B1 (en) * | 2014-01-21 | 2017-08-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
| CN104391999B (zh) * | 2014-12-15 | 2018-02-02 | 北京国双科技有限公司 | 信息推荐方法和装置 |
| CA2991400C (en) * | 2015-07-06 | 2020-05-12 | Public University Corporation Yokohama City University | Phenylsulphonamide derivatives useful as ampa receptor imaging agents |
| RU2634594C1 (ru) * | 2016-11-30 | 2017-11-01 | федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) | Ингибиторы образования конечных продуктов гликирования на основе азопроизводных фенилсульфокислот |
| EP4403185A1 (en) | 2021-09-15 | 2024-07-24 | University of The Ryukyus | Pharmaceutical composition for treating cognitive decline or for treating overweightness or obesity |
| WO2023042887A1 (ja) | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU191702B (en) * | 1984-06-27 | 1987-03-30 | Gyogyszerkutato Intezet | New process for preparing 1-aryl-5 h-2,3-benzodiazepines |
| HU191698B (en) * | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
| HU198494B (en) * | 1986-08-15 | 1989-10-30 | Gyogyszerkutato Intezet | Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same |
| HU219778B (hu) | 1990-12-21 | 2001-07-30 | Gyógyszerkutató Intézet Közös Vállalat | Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények |
| HU206719B (en) | 1990-12-21 | 1992-12-28 | Gyogyszerkutato Intezet | Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them |
| HU219777B (hu) * | 1993-07-02 | 2001-07-30 | Gyógyszerkutató Intézet Kft. | Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására |
| DE4428835A1 (de) * | 1994-08-01 | 1996-02-08 | Schering Ag | Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
| TR199501071A2 (tr) * | 1994-08-31 | 1996-06-21 | Lilly Co Eli | Dihidro-2,3-benzodiazepin türevlerinin üretilmesi icin stereoselektif islem. |
| TR199501070A2 (tr) * | 1994-08-31 | 1996-06-21 | Lilly Co Eli | Dihidro-2,3-benzodiazepin türevinin kristalli bicimi. |
| DE19604919A1 (de) * | 1996-02-01 | 1997-08-07 | Schering Ag | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
-
1998
- 1998-07-08 UA UA2000031380A patent/UA67749C2/ru unknown
- 1998-08-07 DE DE69819166T patent/DE69819166T2/de not_active Expired - Fee Related
- 1998-08-07 RU RU2000106060/04A patent/RU2208013C2/ru not_active IP Right Cessation
- 1998-08-07 EP EP98939781A patent/EP1003749B1/en not_active Expired - Lifetime
- 1998-08-07 NZ NZ503300A patent/NZ503300A/en unknown
- 1998-08-07 US US09/485,391 patent/US6562810B1/en not_active Expired - Fee Related
- 1998-08-07 DK DK98939781T patent/DK1003749T3/da active
- 1998-08-07 JP JP2000506210A patent/JP2001512730A/ja active Pending
- 1998-08-07 PL PL98338680A patent/PL338680A1/xx unknown
- 1998-08-07 CA CA002300302A patent/CA2300302A1/en not_active Abandoned
- 1998-08-07 CN CN98809765A patent/CN1109033C/zh not_active Expired - Fee Related
- 1998-08-07 KR KR1020007001464A patent/KR20010022862A/ko not_active Application Discontinuation
- 1998-08-07 WO PCT/HU1998/000075 patent/WO1999007707A1/en not_active Application Discontinuation
- 1998-08-07 SK SK177-2000A patent/SK1772000A3/sk unknown
- 1998-08-07 AU AU88181/98A patent/AU735490B2/en not_active Ceased
- 1998-08-07 AT AT98939781T patent/ATE252586T1/de not_active IP Right Cessation
- 1998-08-07 BR BR9812120-0A patent/BR9812120A/pt not_active IP Right Cessation
-
2000
- 2000-02-09 NO NO20000655A patent/NO20000655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69819166D1 (de) | 2003-11-27 |
| CN1272846A (zh) | 2000-11-08 |
| DE69819166T2 (de) | 2004-07-22 |
| CA2300302A1 (en) | 1999-02-18 |
| EP1003749A1 (en) | 2000-05-31 |
| KR20010022862A (ko) | 2001-03-26 |
| SK1772000A3 (en) | 2000-10-09 |
| RU2208013C2 (ru) | 2003-07-10 |
| JP2001512730A (ja) | 2001-08-28 |
| EP1003749B1 (en) | 2003-10-22 |
| ATE252586T1 (de) | 2003-11-15 |
| PL338680A1 (en) | 2000-11-20 |
| NZ503300A (en) | 2001-06-29 |
| BR9812120A (pt) | 2001-11-20 |
| AU735490B2 (en) | 2001-07-12 |
| DK1003749T3 (da) | 2004-03-08 |
| NO20000655D0 (no) | 2000-02-09 |
| CN1109033C (zh) | 2003-05-21 |
| AU8818198A (en) | 1999-03-01 |
| WO1999007707A1 (en) | 1999-02-18 |
| UA67749C2 (ru) | 2004-07-15 |
| US6562810B1 (en) | 2003-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA44254C2 (uk) | Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція | |
| DK0808318T3 (da) | Tricykliske, substituerede hexahydrobenz[e]isoindol-alfa-1-adrenerge antagonister | |
| WO1997020823A3 (en) | 2-amino quinazoline derivatives as npy receptor antagonists | |
| GEP20033114B (en) | Biphenyl Sulfonamides as Dual Angiotensin Endothelin Receptor Antagonists, Method for Their Production and Pharmaceutical Compositions Containing the Same | |
| MXPA02011053A (es) | Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos. | |
| GEP19991870B (en) | Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists | |
| NZ336560A (en) | 10,11-dihydro-3-[substituted pyridyl-1-alkoxy]-5H-dibenzo[a,d]cycloheptene-10-acetic acid derivatives useful as vitronectin receptor antagonists | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| NZ514487A (en) | Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands | |
| MX9705675A (es) | Antagonistas alfa-1-adrenergicos de hexahidrobenz[e]isoindol sustituidos biciclicos. | |
| WO2001010846A3 (en) | 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system | |
| WO2002060392A3 (en) | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
| NO20000655L (no) | 8-substituerte-9H-1,3-Dioxolo/4,5- h//2,3/benzodiazepinderivater, som AMPA/KAINAT reseptorinhibitorer | |
| AU1945795A (en) | Thieno{ 2,3-b}indoles, their preparation and use | |
| UA34416C2 (ru) | Производные хромана, активные по отношению к 5-нт рецептору, способ их получения и промежуточные соединения | |
| NZ522195A (en) | Novel amino carboxy alkyl derivatives of barbituric acid, preparation process and use for treating central nervous system disorders thereof | |
| NO973652L (no) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist | |
| IT1276167B1 (it) | Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni | |
| FR2767527B1 (fr) | Derives de piperazines indoliques, utiles comme medicaments et procede de preparation | |
| PT99864A (pt) | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato | |
| GEP19991869B (en) | Amino Acid Derivatives of Substituted Quinoxaline 2,3-Dione Derivatives as Glutamate Receptor Antagonists | |
| ES2168682T3 (es) | Compuestos alfa-1 adrenergicos a base de benzopiranopirrol y de benzopiranopiridina. | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| AR005472A1 (es) | Inhibidores de la formacion cd23 humana soluble, un procedimiento para su preparacion, el uso de los mismos para la manufactura de un medicamento,composicion farmaceutica y compuestos intermediarios | |
| WO2001002340A3 (en) | Novel aminoindanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |